Literature DB >> 25377763

Role for mammalian chitinase 3-like protein 1 in traumatic brain injury.

Clayton A Wiley1, Dafna Bonneh-Barkay, C Edward Dixon, Andrew Lesniak, Guoji Wang, Stephanie J Bissel, Patrick M Kochanek.   

Abstract

Traumatic brain injury (TBI) is accompanied by inflammatory infiltrates and CNS tissue response. The astrocytosis associated with TBI has been proposed to have both beneficial and detrimental effects on surviving neural tissue. We recently observed prominent astrocytic expression of YKL-40/chitinase 3-like protein 1 (CHI3L1) associated with severity of brain injury. The physiological role of CHI3L1 in the CNS is unknown; however, its distribution at the perimeter of contusions and temporal course of expression suggested that in TBI it might be an important component of the astrocytic response to modulate CNS inflammation. To address this hypothesis, we used serially sectioned brains to quantitatively compare the neuropathological outcomes of TBI produced by controlled cortical impact in wild type (WT) and chi3l1 knockout (KO) mice where the murine YKL-40 homologue, breast regression protein 39 (BRP-39/CHI3l1), had been homozygously disrupted. At 21 days post-injury, chi3l1 KO mice displayed greater astrocytosis (increased GFAP staining) in the hemispheres ipsilateral and contralateral to impact compared with WT mice. Similarly, Iba1 expression as a measure of microglial/macrophage response was significantly increased in chi3l1 KO compared with WT in the hemisphere contralateral to impact. We conclude that astrocytic expression of CHI3L1 limits the extent of both astrocytic and microglial/macrophage facets of neuroinflammation and suggests a novel potential therapeutic target for modulating neuroinflammation.
© 2014 Japanese Society of Neuropathology.

Entities:  

Keywords:  BRP-39; chitinase 3-like protein 1; controlled cortical impact; neuroinflammation; traumatic brain injury

Mesh:

Substances:

Year:  2014        PMID: 25377763     DOI: 10.1111/neup.12158

Source DB:  PubMed          Journal:  Neuropathology        ISSN: 0919-6544            Impact factor:   1.906


  19 in total

1.  Ultrastructure of Diaschisis Lesions after Traumatic Brain Injury.

Authors:  Clayton A Wiley; Stephanie J Bissel; Andrew Lesniak; C Edward Dixon; Jonathan Franks; Donna Beer Stolz; Ming Sun; Guoji Wang; Robert Switzer; Patrick M Kochanek; Geoffrey Murdoch
Journal:  J Neurotrauma       Date:  2016-03-30       Impact factor: 5.269

2.  Astroglial activation and altered amyloid metabolism in human repetitive concussion.

Authors:  Pashtun Shahim; Yelverton Tegner; Niklas Marklund; Kina Höglund; Erik Portelius; David L Brody; Kaj Blennow; Henrik Zetterberg
Journal:  Neurology       Date:  2017-03-10       Impact factor: 9.910

3.  Chi3l1/YKL-40 is controlled by the astrocyte circadian clock and regulates neuroinflammation and Alzheimer's disease pathogenesis.

Authors:  Brian V Lananna; Celia A McKee; Melvin W King; Jorge L Del-Aguila; Julie M Dimitry; Fabiana H G Farias; Collin J Nadarajah; David D Xiong; Chun Guo; Alexander J Cammack; Jack A Elias; Jinsong Zhang; Carlos Cruchaga; Erik S Musiek
Journal:  Sci Transl Med       Date:  2020-12-16       Impact factor: 17.956

4.  Hydrogel scaffolds promote neural gene expression and structural reorganization in human astrocyte cultures.

Authors:  V Bleu Knight; Elba E Serrano
Journal:  PeerJ       Date:  2017-01-11       Impact factor: 2.984

5.  YKL-40 in the brain and cerebrospinal fluid of neurodegenerative dementias.

Authors:  Franc Llorens; Katrin Thüne; Waqas Tahir; Eirini Kanata; Daniela Diaz-Lucena; Konstantinos Xanthopoulos; Eleni Kovatsi; Catharina Pleschka; Paula Garcia-Esparcia; Matthias Schmitz; Duru Ozbay; Susana Correia; Ângela Correia; Ira Milosevic; Olivier Andréoletti; Natalia Fernández-Borges; Ina M Vorberg; Markus Glatzel; Theodoros Sklaviadis; Juan Maria Torres; Susanne Krasemann; Raquel Sánchez-Valle; Isidro Ferrer; Inga Zerr
Journal:  Mol Neurodegener       Date:  2017-11-10       Impact factor: 14.195

6.  Neurofilament light and tau as blood biomarkers for sports-related concussion.

Authors:  Pashtun Shahim; Yelverton Tegner; Niklas Marklund; Kaj Blennow; Henrik Zetterberg
Journal:  Neurology       Date:  2018-04-13       Impact factor: 9.910

7.  YKL40 in sporadic amyotrophic lateral sclerosis: cerebrospinal fluid levels as a prognosis marker of disease progression.

Authors:  Pol Andrés-Benito; Raúl Domínguez; Maria J Colomina; Franc Llorens; Mònica Povedano; Isidre Ferrer
Journal:  Aging (Albany NY)       Date:  2018-09-13       Impact factor: 5.682

8.  Frequent monoallelic or skewed expression for developmental genes in CNS-derived cells and evidence for balancing selection.

Authors:  Sergio Branciamore; Zuzana Valo; Min Li; Jinhui Wang; Arthur D Riggs; Judith Singer-Sam
Journal:  Proc Natl Acad Sci U S A       Date:  2018-10-15       Impact factor: 11.205

9.  Shrimp Antiviral mja-miR-35 Targets CHI3L1 in Human M2 Macrophages and Suppresses Breast Cancer Metastasis.

Authors:  Yulei Chen; Siyuan Zhang; Jiao Cao; Xiaobo Zhang
Journal:  Front Immunol       Date:  2018-09-12       Impact factor: 7.561

10.  Assessment of complementarity of WGCNA and NERI results for identification of modules associated to schizophrenia spectrum disorders.

Authors:  Arthur Sant'Anna Feltrin; Ana Carolina Tahira; Sérgio Nery Simões; Helena Brentani; David Corrêa Martins
Journal:  PLoS One       Date:  2019-01-15       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.